Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
5
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
5
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
life sciences
pricing
merck
abeona therapeutics
affordable care act
agios pharmaceuticals
alirocuma
alzheimer's
ameet nathwani
arches
celgene
congress
What
bio
roundup
drug
people
pharmaceutical
american
based
best
continue
crash
debate
healthcare
industry
kind
nash
policy
politicians
pressure
scalps
trump’s
u.s
adu
advanced
alnylam’s
approval
approved
away
beats
bff
bids
biogen
bringing
ceos
complicated
conference
dc
deals
depression
devoted
dire
Language
Current search:
sanofi
×
" bristol-myers squibb "
×
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More